Literature DB >> 29030266

Plasmid-mediated doxycycline resistance in a Yersinia pestis strain isolated from a rat.

Nicolas Cabanel1, Christiane Bouchier2, Minoarisoa Rajerison3, Elisabeth Carniel4.   

Abstract

The emergence of antibiotic-resistant Yersinia pestis strains represents a public health concern. Two antibiotic-resistant Y. pestis strains isolated from Madagascar have been previously identified and characterised. Both strains carried conjugative plasmids that conferred resistance to streptomycin or to multiple antibacterial drugs, respectively. Here we characterised a novel Y. pestis strain (IP2180H) that exhibited resistance to doxycycline. This strain was isolated from a rat in Antananarivo (Madagascar) in 1998. Resistance was carried by a conjugative plasmid (pIP2180H) homologous to pB71 from Salmonella enterica. The plasmid of the previously identified streptomycin-resistant Y. pestis strain was also sequenced and it was found that the three antibiotic resistance Y. pestis plasmids sequenced until now are genetically unrelated and are also unrelated to multidrug resistance plasmids from the phylogenetically close bacterial species Yersinia pseudotuberculosis. The fact that the three antibiotic-resistant Malagasy Y. pestis strains were isolated from different hosts, at different times, from distant locations, and carried unrelated plasmids indicates independent horizontal acquisition of genetic material and further demonstrates the capacity of Y. pestis to acquire antibiotic resistance plasmids under natural conditions. Since these resistance plasmids can frequently carry or easily trap antibiotic resistance cassettes, the emergence of new multidrug-resistant Y. pestis strains may be expected and would represent a major health threat.
Copyright © 2017 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.

Entities:  

Keywords:  IncH1; IncP; Madagascar; Plague; pAAA83; pB71

Mesh:

Substances:

Year:  2017        PMID: 29030266     DOI: 10.1016/j.ijantimicag.2017.09.015

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  19 in total

1.  Yersinia pestis antibiotic resistance: a systematic review.

Authors:  Chen Lei; Suresh Kumar
Journal:  Osong Public Health Res Perspect       Date:  2022-02-18

2.  A Recombinant Attenuated Yersinia pseudotuberculosis Vaccine Delivering a Y. pestis YopENt138-LcrV Fusion Elicits Broad Protection against Plague and Yersiniosis in Mice.

Authors:  Amit K Singh; Roy Curtiss; Wei Sun
Journal:  Infect Immun       Date:  2019-09-19       Impact factor: 3.609

3.  Shift from primary pneumonic to secondary septicemic plague by decreasing the volume of intranasal challenge with Yersinia pestis in the murine model.

Authors:  Rachel M Olson; Deborah M Anderson
Journal:  PLoS One       Date:  2019-05-23       Impact factor: 3.240

Review 4.  Antibiotic Therapy of Plague: A Review.

Authors:  Florent Sebbane; Nadine Lemaître
Journal:  Biomolecules       Date:  2021-05-12

5.  Evaluation of the European Committee on Antimicrobial Susceptibility Testing Guidelines for Rapid Antimicrobial Susceptibility Testing of Bacillus anthracis-, Yersinia pestis- and Francisella tularensis-Positive Blood Cultures.

Authors:  Ohad Shifman; Tamar Aminov; Moshe Aftalion; David Gur; Hila Cohen; Elad Bar-David; Ofer Cohen; Emanuelle Mamroud; Haim Levy; Ronit Aloni-Grinstein; Ida Steinberger-Levy; Shahar Rotem
Journal:  Microorganisms       Date:  2021-05-13

6.  Reporter-Phage-Based Detection and Antibiotic Susceptibility Testing of Yersinia pestis for a Rapid Plague Outbreak Response.

Authors:  Sarit Moses; Moshe Aftalion; Emanuelle Mamroud; Shahar Rotem; Ida Steinberger-Levy
Journal:  Microorganisms       Date:  2021-06-11

7.  Metallacarborane Derivatives Effective against Pseudomonas aeruginosa and Yersinia enterocolitica.

Authors:  Wieslaw Swietnicki; Waldemar Goldeman; Mateusz Psurski; Anna Nasulewicz-Goldeman; Anna Boguszewska-Czubara; Marek Drab; Jordan Sycz; Tomasz M Goszczyński
Journal:  Int J Mol Sci       Date:  2021-06-23       Impact factor: 5.923

8.  Modeling the Cost-Effectiveness of Interventions to Prevent Plague in Madagascar.

Authors:  Giovanni S P Malloy; Margaret L Brandeau; Jeremy D Goldhaber-Fiebert
Journal:  Trop Med Infect Dis       Date:  2021-06-11

9.  Targeting of the Yersinia pestis F1 capsular antigen by innate-like B1b cells mediates a rapid protective response against bubonic plague.

Authors:  Yinon Levy; Yaron Vagima; Avital Tidhar; Moshe Aftalion; David Gur; Uri Nili; Theodore Chitlaru; Ayelet Zauberman; Emanuelle Mamroud
Journal:  NPJ Vaccines       Date:  2018-10-19       Impact factor: 7.344

10.  Yersinia pestis Exploits Early Activation of MyD88 for Growth in the Lungs during Pneumonic Plague.

Authors:  Rachel M Olson; Miqdad O Dhariwala; William J Mitchell; Deborah M Anderson
Journal:  Infect Immun       Date:  2019-03-25       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.